0001821825-24-000049.txt : 20240403 0001821825-24-000049.hdr.sgml : 20240403 20240403184208 ACCESSION NUMBER: 0001821825-24-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WALSH MATTHEW M CENTRAL INDEX KEY: 0001269428 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40235 FILM NUMBER: 24820739 MAIL ADDRESS: STREET 1: ALLERGAN STREET 2: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organon & Co. CENTRAL INDEX KEY: 0001821825 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464838035 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 551-430-6000 MAIL ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 4 1 wk-form4_1712184118.xml FORM 4 X0508 4 2024-03-31 0 0001821825 Organon & Co. OGN 0001269428 WALSH MATTHEW M C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33 JERSEY CITY NJ 07302 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-03-31 4 M 0 7753 0 A 81815 D Common Stock 2024-03-31 4 F 0 3819 18.80 D 77996 D Common Stock 2024-03-31 4 M 0 12046 0 A 90042 D Common Stock 2024-03-31 4 F 0 5933 18.80 D 84109 D Restricted Stock Units 2024-03-31 4 M 0 7753 0 D Common Stock 7753 7754 D Restricted Stock Units 2024-03-31 4 M 0 12046 0 D Common Stock 12046 24093 D Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. /s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh 2024-04-03